Clinical Trial

Multiple Ascending Dose Study of NH102 in Healthy Subjects

Name: Multiple Ascending Dose Study of NH102 in Healthy Subjects — clinical trial record (NCT07324408)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 1

View on ClinicalTrials.gov →

Summary

The purpose of this study is to assess the safety, tolerability and pharmacokinetics (PK) of NH102 when administered as multiple oral dose at escalating dose levels in healthy participants.

Trial Details

NCT Number	NCT07324408
Lead Sponsor	Jiangsu Nhwa Pharmaceutical Co., Ltd.
Conditions	Depression
Enrollment	40 participants
Start Date	2022-03-10
Primary Completion	2023-04-10 (estimated)
Study Completion	2023-04-10 (estimated)
Updated on ClinicalTrials.gov	2026-01-07